NCT06848166View on ClinicalTrials.gov

Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

May 31, 2027

Conditions
Chronic Migraine Headache
Interventions
DEVICE

liquid embolic agent SQUID 12, liquid embolic agent SQUID 18

Total endovascular embolization of the frontal and parietal branches (less often the occipital branch) of the middle meningeal artery (MMA) with its complete devascularization. In the case of unilateral pain localization, ipsilateral MMA embolization will be performed; in the case of bilateral pain localization, total embolization of both MMA branches will be performed.

Trial Locations (1)

720054

RECRUITING

Vedanta University Clinic, Bishkek

All Listed Sponsors
lead

Vedanta University Clinic

OTHER